diabetes so far... and the Finnish vaccine is under trial

A consultant in public health and family and community medicine, Professor Tawfiq Khoja, revealed that Finland''s delivery of a vaccine to treat type 1 diabetes is still subject to clinical trials and studies. Noting that it cannot be confirmed globally during this period Such therapeutic productions go through a series of studies, experiments and approvals by the competent health authorities.

He explained that in 2017, Finnish scientists produced a vaccine against type 1 diabetes, and it was tested on laboratory mice.

Scientists at the Finnish Universities of Tampere and Helsinki said at the time: “The enterovirus is an important factor in the development of first-degree diabetes, which appears most often during childhood.” This virus enters the pancreas, where it destroys insulin-producing cells.

And if clinical trials in humans are successful at a significant level It is expected that the serum will be widely used in medical practices after five to eight years, and after passing a series of global approvals, including the Food and Drug Administration.

busy research centers

He said: Diabetes is one of the diseases that preoccupied global research and studies centers, in order to find treatments that end or alleviate the suffering of patients. The development witnessed by the treatment of diabetes, whether in terms of medicines, insulin, testing devices and glucose meters, has witnessed a significant development from the past, but time is still Early to confirm treatment with injections and the pancreas returning to function as it should.

Stem cell risks

Prof. Khoja warned diabetic patients not to be drawn into the issue of stem cells, which some third parties are calling for to treat diabetes and to get rid of the daily suffering of insulin.

He explained that the Ministry of Health warned - a few days ago - against being drawn into rumors calling for stem cell therapy, and called on everyone to take information from its official sources.

She pointed out that stem cells are a high-risk medical procedure, carried out under strict medical supervision, and their cultivation is a complex and delicate process, and is used only to treat some of the following cases: acute leukemia, lymphomas that did not respond to treatment, bone marrow failure, multiple myeloma, and stressed on the Stem cells have not been shown to be effective in treating other conditions Stem cells are not used in: diabetes treatment, anti-aging, heart disease, stroke, arthritis and erosion, Parkinson''s and Alzheimer''s, or all kinds of paralysis.

Keeping abreast of global developments

Khoja said: The Kingdom - represented by the Ministry of Health and the Food and Drug Authority - keeps pace with all global developments in the health field in all pathological disciplines, whether in the aspect of therapeutic drugs or technical devices, as well as keeping pace with any global treatments that serve patients.

He added: It is not excluded that, in the coming years, we will witness medical achievements that serve diabetics, and all of this calls me to warn patients not to engage in any experiments that some centers call for in order to end the disease In fact, their goal is to attract these patients and drain their pockets All of this is only a stage of the experiences in which many victims fall and return again to the previous treatments prescribed to them by doctors.

Sports and healthy food

Professor Khoja advised all members of society to avoid diabetes by maintaining a normal weight. Belly fat poses a major threat to health, and regular exercise (all forms of exercise) Because they help prevent the development of diabetes, including walking for 30 minutes, eating healthy foods, limiting fats, salt and sugar, making sure to eat meals rich in fiber, and avoiding soft drinks as they contain a large amount of sugar, and consuming them means raising blood sugar levels. enhance insulin resistance He explained that it is better to eat fresh water and juices, and limit caffeinated drinks